172 related articles for article (PubMed ID: 22429502)
1. Hepatocellular adenoma subtypes: the impact of overweight and obesity.
Bioulac-Sage P; Taouji S; Possenti L; Balabaud C
Liver Int; 2012 Sep; 32(8):1217-21. PubMed ID: 22429502
[TBL] [Abstract][Full Text] [Related]
2. Changing trends in malignant transformation of hepatocellular adenoma.
Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype.
Huang WC; Liau JY; Jeng YM; Liu KL; Lin CN; Song HL; Tsai JH
J Gastroenterol Hepatol; 2020 Apr; 35(4):680-688. PubMed ID: 31698521
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
[TBL] [Abstract][Full Text] [Related]
5. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
6. Subtype classification of hepatocellular adenoma.
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
8. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and natural history of hepatocellular adenomas: the impact of obesity.
Bunchorntavakul C; Bahirwani R; Drazek D; Soulen MC; Siegelman ES; Furth EE; Olthoff K; Shaked A; Reddy KR
Aliment Pharmacol Ther; 2011 Sep; 34(6):664-74. PubMed ID: 21762186
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory and multiple hepatocellular adenoma are associated with a higher BMI.
Bröker MEE; Gaspersz MP; Klompenhouwer AJ; Hansen BE; Terkivatan T; Taimr P; Dwarkasing R; Thomeer MGJ; de Man RA; IJzermans JNM
Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1183-1188. PubMed ID: 28704224
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
13. Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population.
Liu HP; Zhao Q; Jin GZ; Qian YW; Gu YJ; Dong H; Lu XY; Cong WM; Wu MC
Pathol Res Pract; 2015 Dec; 211(12):918-24. PubMed ID: 26608415
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
Blanc JF; Frulio N; Chiche L; Sempoux C; Annet L; Hubert C; Gouw AS; de Jong KP; Bioulac-Sage P; Balabaud C
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):180-7. PubMed ID: 25434466
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
Poulain M; Doucet M; Drapeau V; Fournier G; Tremblay A; Poirier P; Maltais F
Chron Respir Dis; 2008; 5(1):35-41. PubMed ID: 18303100
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
17. Will weight loss become a future treatment of hepatocellular adenoma in obese patients?
Dokmak S; Belghiti J
Liver Int; 2015 Oct; 35(10):2228-32. PubMed ID: 26216699
[TBL] [Abstract][Full Text] [Related]
18. Gene mutations in hepatocellular adenomas.
Raft MB; Jørgensen EN; Vainer B
Histopathology; 2015 Jun; 66(7):910-21. PubMed ID: 25195525
[TBL] [Abstract][Full Text] [Related]
19. Regression of hepatocellular adenoma after bariatric surgery in severe obese patients.
Gevers TJG; Marcel Spanier BW; Veendrick PB; Vrolijk JM
Liver Int; 2018 Dec; 38(12):2134-2136. PubMed ID: 30025198
[TBL] [Abstract][Full Text] [Related]
20. Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria.
Miller GC; Campbell CM; Manoharan B; Bryant R; Cavallucci D; O'Rourke N; Clouston AD
Pathology; 2018 Oct; 50(6):593-599. PubMed ID: 30149989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
